Journal of neurology · 2024
Regional distribution of polymorphisms associated to the disease-causing gene of spinocerebellar ataxia type 3.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Elter Tim Lukas, Sturm Daniel, Santana Magda M, Schaprian Tamara, Raposo Mafalda, Melo Ana Rosa Vieira, Lima Manuela, Koyak Berkan, Oender Demet, Grobe-Einsler Marcus, Lopes Sara, Silva Patrick, de Almeida Luís Pereira, Giunti Paola, Garcia-Moreno Hector, Nethisinhe Suran, de Vries Jeroen, van de Warrenburg Bart P, van Gaalen Judith, Synofzik Matthis, Schöls Ludger, Reetz Kathrin, Erdlenbruch Friedrich, Jacobi Heike, Infante Jon, Riess Olaf, Klockgether Thomas, ESMI study group, Faber Jennifer, Hübener-Schmid Jeannette
Аннотация
INTRODUCTION: Knowledge about the distribution and frequency of the respective haplotypes on the wildtype and mutant allele is highly relevant in the context of future gene therapy clinical studies in Spinocerebellar Ataxia Type 3, the most common autosomal dominantly inherited ataxia. Single nucleotide polymorphisms associated to the disease-causing gene, ATXN3, have been determined. We wanted to investigate the frequency and regional distribution of two intragenic single nucleotide polymorphisms (SNPs) in a large European SCA3 cohort and their relation to the clinical phenotype.
METHODS: The genotypes of the two polymorphisms at base pair positions 987 and 1118 of the ATXN3 were determined for their co-localization on the normal and expanded allele, respectively, in 286 SCA3 mutation carriers and 117 healthy controls from 11 European sites.
RESULTS: The distribution of genotypes on the expanded allele differed from those of the wildtype allele of SCA3 mutation carriers and of healthy controls, and was mainly influenced by the regional origin. In our cohort, no particular clinical phenotype was associated with any specific haplotype.
CONCLUSIONS: Our results confirm distinct allocations of SNPs associated to the expanded ATXN3, and accordingly the consideration of allele-specific therapies.
METHODS: The genotypes of the two polymorphisms at base pair positions 987 and 1118 of the ATXN3 were determined for their co-localization on the normal and expanded allele, respectively, in 286 SCA3 mutation carriers and 117 healthy controls from 11 European sites.
RESULTS: The distribution of genotypes on the expanded allele differed from those of the wildtype allele of SCA3 mutation carriers and of healthy controls, and was mainly influenced by the regional origin. In our cohort, no particular clinical phenotype was associated with any specific haplotype.
CONCLUSIONS: Our results confirm distinct allocations of SNPs associated to the expanded ATXN3, and accordingly the consideration of allele-specific therapies.